We are live on ! Find out more
NURO

NeuroMetrix, Inc. Common Stock
NURO

Delisted

NURO was delisted on the 1st of May, 2025.

Back to rankings

13 hedge funds and large institutions have $1.01M invested in NeuroMetrix, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

18% more funds holding

Funds holding: 11 → 13 (+2)

17% more capital invested

Capital invested by funds: $867K → $1.01M (+$145K)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
13
Holders Change
+2
Holders Change %
+18.18%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$96.3K
2
Millennium Management
Millennium Management
New York
+$56.2K
3
SM
Sabby Management
Florida
+$36.7K
4
Goldman Sachs
Goldman Sachs
New York
+$18.8K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$15.1K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$46K
2
TDC
Thompson Davis & Co
Virginia
-$44.5K
3
Citadel Advisors
Citadel Advisors
Florida
-$20K
4
TSS
Two Sigma Securities
New York
-$1.52K
5
UBS Group
UBS Group
Switzerland
-$1.01K

NURO Hedge Fund Activity: Q3 2018 in Review

13 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q3 2018, worth a combined $1.01M — up 17% from $867K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new NURO positions and 2 closed out — a net gain of 2 holders — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $96.3K. The largest seller was Virtu Financial, exiting entirely with an estimated $46K sold.

  • 13 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q3 2018, up from 11 in Q2 2018.
  • Funds reported $1.01M of NeuroMetrix, Inc. Common Stock stock for Q3 2018, up 17% quarter-over-quarter.
  • 4 funds opened new NeuroMetrix, Inc. Common Stock positions in Q3 2018 and 2 closed out, a net change of +2 holders.
  • The largest NeuroMetrix, Inc. Common Stock buyer in Q3 2018 was Renaissance Technologies, an estimated $96.3K added.
  • The largest NeuroMetrix, Inc. Common Stock seller in Q3 2018 was Virtu Financial, an estimated $46K sold.

Based on aggregated 13F filings for Q3 2018.